| JLMOX | JNBZX | JLMOX / JNBZX | |
| Total Expense Ratio | 0.73 | 0.52 | 140% |
| Annual Report Gross Expense Ratio | 0.74 | 0.57 | 130% |
| Fund Existence | 12 years | 8 years | - |
| Gain YTD | 12.307 | 13.500 | 91% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 15000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 492M | 8.56B | 6% |
| Annual Yield % from dividends | 2.93 | 5.62 | 52% |
| Returns for 1 year | 11.59 | 12.76 | 91% |
| Returns for 3 years | 28.92 | 32.85 | 88% |
| Returns for 5 years | 14.77 | 21.07 | 70% |
| Returns for 10 years | 52.54 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IJUL | 33.56 | 0.05 | +0.16% |
| Innovator Intl Dev Pwr Bffr ETF July | |||
| FFOX | 28.38 | 0.03 | +0.12% |
| Fundx Future Fund Opportunities ETF | |||
| SEIM | 47.02 | -0.03 | -0.06% |
| SEI Enhanced US Large Cap Momt Fac ETF | |||
| FSCC | 30.72 | -0.02 | -0.07% |
| Federated Hermes MDT Small Cap Core ETF | |||
| BBP | 81.63 | -0.99 | -1.20% |
| Virtus LifeSci Biotech Products ETF | |||